A. Covelli

发表

P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia.

L. Möllgård, G. Juliusson, B. Gustavsson, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of clustered circulating tumour cells in early breast cancer

P. Milani, F. Castro-Giner, N. Aceto, 2021, British Journal of Cancer.

The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries

M. Baccarani, R. Clark, K. Indrák, 2015, Leukemia.

High‐dose ARA‐C (HiDAC) plus asparaginase in elderly patients with acute non‐lymphocytic leukemia: A pilot multicentric study by the Italian cooperative group GIMEMA

F. Mandelli, G. Leone, G. Avvisati, 1989, European journal of haematology.

In vitro pharmacological purging of human bone marrow is enhanced by the use of lonidamine.

F. Mandelli, G. Zupi, A. Pulsoni, 1989, Experimental and molecular pathology.

Hemoglobin synthesis in individual bursts from normal adult blood: all bursts and subcolonies synthesize G gamma-and A gamma-globin chains

Cappellini, C. Peschle, M. Condorelli, 1980 .

Hemoglobin synthesis in individual bursts from normal adult blood: all bursts and subcolonies synthesize G gamma-and A gamma-globin chains.

C. Peschle, M. Condorelli, A. Migliaccio, 1980, Blood.

Globin chain synthesis in single erythroid bursts from cord blood: studies on gamma leads to beta and G gamma leads to A gamma switches.

C. Peschle, M. Condorelli, G. Migliaccio, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia

J. Chang, R. Marcus, R. Powles, 2001, Leukemia.

Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC).

R. Advani, P. Greenberg, B. Sikic, 1999, Advances in experimental medicine and biology.

Modulation of multidrug resistance (MDR) in hematological malignancies.

A. Covelli, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204.

F. Mandelli, G. Masera, A. Ceci, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The pharmaceutical industry and oncology in central and eastern Europe.

M. Ben-Am, G. Burke, A. Covelli, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Chronic lymphocytic leukemia (CLL) in younger adults: A retrospective study of 133 cases

F. Mandelli, M. Martelli, M. Luciani, 1989, Hematological oncology.

Autologous Bone Marrow Transplantation for Patients with Acute Myelogenous Leukemia in Complete Remission

F. Mandelli, G. Meloni, A. Pulsoni, 1987, Annals of the New York Academy of Sciences.

Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus.

C. Peschle, P. P. Di Fiore, G. Colletta, 1983, Cancer research.

The early stage of Friend virus erythroleukemias: mechanisms underlying BPA-"independent" in vitro growth of BFU-E.

C. Peschle, A. Migliaccio, G. Migliaccio, 1983, Haematology and blood transfusion.